Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70
Michelle E Orme,1 Katherine S MacGilchrist,2 Stephen Mitchell,2 Dean Spurden,3 Alex Bird31Icera Consulting, Swindon, Wiltshire, UK; 2Systematic Review Department, Abacus International, Bicester, Oxfordshire, UK; 3Pfizer UK Limited, Tadworth, Surrey, UKBackground: Biologic disease-modifying antirheum...
Guardado en:
Autores principales: | Orme ME, MacGilchrist KS, Mitchell S, Spurden D, Bird A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30ed3a41729943ef80d1ab0b1c76f980 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Students Who Experienced Foster Care are on Campus: Are Colleges Ready?
por: Sarah Jones, et al.
Publicado: (2021) -
Rheumatology
Publicado: (1999) -
Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis.
por: Gia Deyab, et al.
Publicado: (2021) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021) - Modern rheumatology